Fundraising FoxAthenex
Buffalo, US · Delaware corporation · 4 known investors
Find your way into Athenex
Sign up to see every warm intro you have to Athenex
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Athenex team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
WZ
William ZuoExecutive
RK
Rudolf KwanExecutive
Board
AL
Antony LeungBoard director
KC
Kim CampbellBoard director
MF
Manson FokBoard director
JW
Jinn WuBoard director
Investors · 4
Avoro Capital Advisorslisted by Avoro Capital AdvisorsNew York
How we know: Avoro Capital Advisors's portfolio page · proactiveinvestors.com · Not right? Tell us
Salica Investmentslisted by Salica InvestmentsLondon
How we know: the VCSheet dataset · Not right? Tell us
Also in the syndicate · 1
Perceptive Advisors
Reported raises · per SEC filings
Form D private placements$352.7M disclosed across 7 rounds · 2015–2019
▶$60.4MraisedDec 2019 · 5 investors · PharmaceuticalsRule 506(b)
▶$60.4MraisedDec 2019 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Johnson LauExecutive Officer, Director
- Randoll SzeExecutive Officer
- Jeffrey YordonExecutive Officer
- Rudolf KwanExecutive Officer
- Simon PedderExecutive Officer
- Jinn WuDirector
- John VierlingDirector
- Benson TsangDirector
- John KohDirector
- Jordan KanferDirector
- Manson FokDirector
- Stephanie DavisDirector
- William ZuoExecutive Officer
- Kim CampbellDirector
- Offering amount
- $60.4M
- Amount sold
- $60.4M
- Sales commissions
- $1M
- Placement agents
- SunTrust Robinson Humphrey, Inc.
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$100MraisedMay 2019 · 4 investors · PharmaceuticalsRule 506(b)
▶$100MraisedMay 2019 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Manson FokDirector
- Jordan KanferDirector
- John KohDirector
- Benson TsangDirector
- John VierlingDirector
- Jinn WuDirector
- Johnson LauExecutive Officer, Director
- Randoll SzeExecutive Officer
- Jeffrey YordonExecutive Officer
- Rudolf KwanExecutive Officer
- Simon PedderExecutive Officer
- William ZuoExecutive Officer
- Kim CampbellDirector
- Stephanie DavisDirector
- Offering amount
- $100M
- Amount sold
- $100M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$50MraisedJul 2018 · 1 investors · PharmaceuticalsRule 506(b)
▶$50MraisedJul 2018 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Manson FokDirector
- SongYi ZhangDirector
- Simon PedderExecutive Officer
- Li ShenExecutive Officer
- Jeffrey YordonExecutive Officer
- Benson Kwan Hung TsangDirector
- Rudolf KwanExecutive Officer
- Jinn WuDirector
- William ZuoExecutive Officer
- Johnson LauExecutive Officer
- Kim CampbellDirector
- Sheldon Trainor-DegirolamoDirector
- Offering amount
- $50M
- Amount sold
- $50M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20MraisedMay 2017 · 1 investors · BiotechnologyRule 506(b)
▶$20MraisedMay 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Manson FokDirector
- Jeffrey YordonExecutive Officer
- Song-Yi ZhangDirector
- Nick RiehleExecutive Officer
- Rudolph KwanExecutive Officer
- Johnson LauExecutive Officer, Director
- Simon PedderExecutive Officer
- William ZuoExecutive Officer
- Jinn WuDirector
- Antony LeungDirector
- Kim CampbellDirector
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$37.9MraisedOct 2016 · 5 investors · BiotechnologyRule 506(b)
▶$37.9MraisedOct 2016 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Flint BeseckerExecutive Officer, Director
- Li ShenExecutive Officer
- Simon PedderExecutive Officer
- Johnson LauExecutive Officer, Director
- William ZuoExecutive Officer
- Kim CampbellDirector
- Rudolf KwanExecutive Officer
- Manson FokDirector
- Jinn WuDirector
- Antony LeungDirector
- Jeffrey YordonExecutive Officer
- James HusseyExecutive Officer
- Song-Yi ZhangDirector
- Offering amount
- $50M
- Amount sold
- $37.9M
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedJun 2015 · 2 investors · BiotechnologyRule 506(b)
▶$10MraisedJun 2015 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Johnson LauExecutive Officer, Director
- Jinn WuDirector
- Flint BeseckerExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Apr 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$74.4MraisedJun 2015 · 9 investors · BiotechnologyRule 506(b)
▶$74.4MraisedJun 2015 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Flint BeseckerExecutive Officer, Director
- Johnson LauExecutive Officer, Director
- Jinn WuDirector
- Amount sold
- $74.4M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Athenex's investors?
- Athenex's investors include Avoro Capital Advisors, Salica Investments, OrbiMed.
- How much funding has Athenex raised?
- Athenex has disclosed $352.7M raised across 7 rounds.
- Where is Athenex headquartered?
- Athenex is headquartered in Buffalo, US.